JORDAN MYERS: Open Payments
NPI 1841714193 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 108 payments from 20 companies in 2025. Trend: 2023 $150 · 2024 $1,247 · 2025 $1,607
Food & beverage: $1,607
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $346 |
| AstraZeneca Pharmaceuticals LP | 11 | $272 |
| Novo Nordisk Inc | 15 | $192 |
| Amgen Inc. | 17 | $143 |
| Lilly USA, LLC | 4 | $68 |
| Exact Sciences Corporation | 4 | $67 |
| Noven Therapeutics, LLC | 3 | $66 |
| Axsome Therapeutics, Inc. | 4 | $57 |
| Dexcom, Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $46 |
Products named: FARXIGA, UBRELVY, VRAYLAR, Wegovy, EVENITY, MOUNJARO, Xelstrym, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
